Gen-Plus and Conscio Group enter into a strategic partnership
Gen-Plus and Conscio Group enter into a strategic partnership to become an end-to-end solutions provider for cutting-edge pharmaceutical technologies
Munich, August 11, 2022
Gen-Plus GmbH & Co. KG ("Gen-Plus") has decided to merge with Conscio Holding GmbH ("Conscio Group"), an independent international network of scientific service providers. The partnership strengthens Conscio's innovative power and enables Conscio to provide an optimal service offering to its customers. Together, Gen-Plus and the Conscio Group will be in an optimal position to support their customers in developing innovative products for end users and patients.
Dr. Dachtler, Managing Director of Gen-Plus, explains, "By joining forces with Conscio Group, we will be able to offer small and large pharmaceutical customers a truly unique 'end-to-end' service offering, from idea to commercialization. Gen-Plus supports product idea development, compound screening, formulation and GMP production. Conscio adds in-house clinical trials, bioanalytical testing, comprehensive pharmaceutical testing, etc. I believe Conscio is the perfect partner for the next growth phase of Gen-Plus. Our service portfolios are highly complementary, we share the same culture and values, and our continued independence is guaranteed." Dr. Dachtler will remain Managing Director of Gen-Plus and become a member of the Conscio Group Executive Committee.
Dr. Wolfhart Hauser, Chairman of the Advisory Board of Conscio Group, added: "Gen-Plus offers unique technology and innovation capabilities through its extensive project experience. The continuous investment in new capabilities enables Gen-Plus to develop better medicines for patients. We were impressed by the company's relentless focus on its customers, its agile way of working and its scientific work at the highest level, which is in line with Conscio Group's values. We look forward to working with Dr. Dachtler and the entire team at Gen-Plus to further grow and develop the company."
Translated with www.DeepL.com/Translator (free version)